Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

23ANDME HOLDING CO.

(ME)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Medical & Diagnostic Laboratories
02:19aSYNLAB : Raised to Buy by Barclays
MD
01/12China's Tianjin outbreak grows as Omicron spreads to Dalian
RE
01/11SYNLAB : JP Morgan sticks Neutral
MD
01/07SYNLAB : Jefferies reiterates its Buy rating
MD
01/07Synlab Buys Spain's Sistemas Genómicos to Boost Genetics Offering
MT
01/07SYNLAB AG (DB : SYAB) acquired Sistemas Genomicos S.L. from Ascires Biomedical Group.
CI
01/04SYNLAB : JP Morgan reaffirms its Neutral rating
MD
2021Gold, banking stocks drive Australian shares up as Omicron worries ease
RE
2021Sonic Healthcare Limited acquired ProPath Laboratory, Inc.
CI
2021Sonic Healthcare Acquires Texas-Based Anatomical Pathology Company
MT
2021SYNLAB : Deutsche Bank reiterates its Buy rating
MD
2021SYNLAB : Deutsche Bank remains its Buy rating
MD
2021Sonic Healthcare Limited Signs an Agreement with Harrison.ai to Form a Joint Venture Co..
CI
2021Harrison-AI Pty Ltd announced that it has received AUD 129 million in funding from Hori..
CI
2021SYNLAB : Goldman Sachs maintains a Buy rating
MD
2021Bruxelles Lambert, Others Bid For $5 Billion Diagnostics Firm Unilabs
MT
2021Dr. Lal Pathlabs Completes Acquisition of Suburban Diagnostics (India)
MT
2021Dr. Lal PathLabs Limited completed the acquisition of Suburban Diagnostics Private Limi..
CI
2021SYNLAB : JP Morgan sticks Neutral
MD
2021SYNLAB : Deutsche Bank reiterates its Buy rating
MD
2021SYNLAB : Barclays reaffirms its Neutral rating
MD
2021SYNLAB : Goldman Sachs keeps its Buy rating
MD
2021SYNLAB : JP Morgan reaffirms its Neutral rating
MD
2021SYNLAB : Jefferies reaffirms its Buy rating
MD
2021SYNLAB Boosts FY21 Outlook from IPO Goals
MT
2021SYNLAB : Deutsche Bank keeps its Buy rating
MD
2021SYNLAB Completes Purchase of Mexican Diagnostics Services Providers
MT
2021Certain Ordinary Bearer Shares of SYNLAB AG are subject to a Lock-Up Agreement Ending o..
CI
2021Dr. Lal PathLabs' Consolidated Profit Climbs in Fiscal Q2 But Misses Estimates
MT
2021Dr. Lal PathLabs to Acquire Indian Diagnostics Chain for Over $123 Million
MT
2021Dr. Lal PathLabs Limited Reports Earnings Results for the Second Quarter and Six Months..
CI
2021Dr. Lal PathLabs Limited entered into a definitive agreement to acquire Suburban Diagno..
CI
2021Guangzhou Kingmed Diagnostics Group Co., Ltd. Reports Earnings Results for the Nine Mon..
CI
2021SYNLAB : Jefferies gives a Buy rating
MD
2021SYNLAB : Deutsche Bank reiterates its Buy rating
MD
2021SYNLAB : Kepler Cheuvreux remains its Buy rating
MD
2021SYNLAB : Gets a Buy rating from Jefferies
MD
2021SYNLAB : JP Morgan reiterates its Neutral rating
MD
2021SYNLAB : Goldman Sachs reaffirms its Buy rating
MD
2021SYNLAB Ag Provides Earnings Guidance for the Fiscal Year 2021
CI
2021SYNLAB : Barclays reiterates its Neutral rating
MD
2021SYNLAB Expands Partnership with Feedtrail to Gain Real-Time Patient and Customer Feedba..
CI
2021SYNLAB : Deutsche Bank maintains a Buy rating
MD
2021SYNLAB : Deutsche Bank reaffirms its Buy rating
MD
2021SYNLAB AG(XTRA : SYAB) added to S&P Global BMI Index
CI
2021SYNLAB AG(XTRA : SYAB) added to Germany SDAX (Total Return) Index
CI
2021SYNLAB : Deutsche Bank keeps its Buy rating
MD
2021SYNLAB : Barclays sticks Neutral
MD
2021SYNLAB : Goldman Sachs gives a Buy rating
MD
2021Australia's bumper earnings get Delta reality check
RE
1  2  3  4  5  6Next
Upcoming event on 23ANDME HOLDING CO.
01/18/22R&D Day